The Harmonic™ trial is a Phase 2 multi-center study focused on never smokers with advanced non-small cell lung cancer (NSCLC) and will begin patient enrollment during Q3 2022. In a previous Phase 3 multi-center clinical trial, a subset of never smoker patients with NSCLC receiving LP-300 with chemotherapy showed increased overall and two-year survival of … [Read more…]

LAWRENCE, Kan.–(BUSINESS WIRE)–Endpoints News, the biopharma industry’s leading source for daily news and analysis, announced today the expansion of its editorial team with the appointments of Jared Whitlock as Features Editor and Aayushi Pratap as News Reporter. Jared Whitlock has written for a variety of publications, including The New York Times, WIRED, STAT and the … [Read more…]

FDA Defers Action on BLA Until Required Inspections Can Be Completed Due to COVID Travel Restrictions, Inspections Could Not Be Completed During Review Period CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and … [Read more…]

The hospital is one of only a few institutions in the country to allow parents to stay in the same room with their child during the treatment. LOS ANGELES–(BUSINESS WIRE)–Children with high-risk neuroblastoma can now access a specialized, targeted radiation treatment called MIBG therapy at Children’s Hospital Los Angeles—one of the largest neuroblastoma programs in … [Read more…]

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 vaccine (CoronaVac) has been approved by the Brazilian Health Regulatory Agency (Anvisa) for emergency use in children from 3 to 5 years old on 13 July. These children will receive the same dose … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The global cloud-based solutions for drug discovery, development, and manufacturing market is expected to register a CAGR of 12.5% during the forecast period of the study. As … [Read more…]

Ferring’s new family building benefits package for its employees includes financial support and a generous 26-week global minimum standard of paid parental leave for birthing and non-birthing parents No cap on the amount of financial support available on its fertility benefit providers’ services, and accessible to all employees, regardless of their role, location, or specific … [Read more…]

Press Teleconference: Thurs., July 14 @ 10:00 am PT With case numbers increasing rapidly in L.A. and elsewhere and extremely limited vaccine doses available nationwide, AHF will propose the Los Angeles County Department of Public Health implement a six-point plan to ramp up education on the virus and its prevention as well as share surveillance … [Read more…]

– Toward disseminating cutting-edge life sciences information on Wednesday, July 20, 2022 – TOKYO–(BUSINESS WIRE)–The Japan Analytical Instruments Manufacturers’ Association (hereinafter “JAIMA”; location: 2-5-16 Kanda Nishiki-cho, Chiyoda-ku, Tokyo, 101-0054 Japan; president: Akira Nakamoto; senior corporate advisor: Shimadzu Corporation) announces that, on Wednesday July 20, 2022, it will jointly hold the second online “Japan-China Scientists Forum … [Read more…]

Common Shares Priced at US$9.25 per Share LAVAL, Quebec–(BUSINESS WIRE)–In connection with its previously announced public offering of common shares in Canada and the United States (the “Offering”), BELLUS Health Inc. (“BELLUS Health” or the “Company”) (TSX and Nasdaq: BLU) today announced that it has entered into an underwriting agreement with Jefferies, Evercore ISI and … [Read more…]